GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Clindamycin

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Stanford adult Clindamycin

Product / population
Adult institutional dosing; not a manufacturer-label replacement.
Renal method
Not specified
Source revision
Antibiotic Subcommittee approved August 2026
Retrieved
2026-09-05
Local review status
Source-read local summary; source-specific recommendations are not automatically interchangeable.
Professional

Stanford adult Clindamycin

Open original reference

Stanford Antimicrobial Safety and Sustainability Program · Adult institutional dosing; not a manufacturer-label replacement.

Renal method: Not specified in this summary.
Source date: Antibiotic Subcommittee approved August 2026
Retrieved: 2026-09-05

Source-read local summary; source-specific recommendations are not automatically interchangeable.

Source-specific regimen

Adults: 600-900 mg IV every 8 hours or 150-450 mg orally every 6 hours. The table specifies no renal, HD or CRRT change.

clindamycin:stanford-clindamycin-1 · Source locator: PDF page 3, Clindamycin row

Source identity and provenance
Source
https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-ABX-Dosing-Guide.pdf
Retrieved
2026-09-05
Source date/version
Antibiotic Subcommittee approved August 2026
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
72b3c311924676315bdce147ddc1c7e5ae04fb66a105381de66d4fb5e5b4f933

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=clindamycin&s1=stanford-clindamycin&h1=6a6ebff1144746a4c5782e774d51a21b5e2478c300038f193f894a2f7d5d5862